Biotech

All Articles

Nuvation standstills wager prevention after looking at period 1 record

.After looking at stage 1 data, Nuvation Biography has made a decision to stop deal with its own sin...

' Professional instinct' led FDA advisors to back Zevra's rare illness med

.Zevra Therapies' unusual condition drug seems to become on the pathway to confirmation this loss af...

Pfizer takes $230M attacked after axing neglected DMD genetics therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics therapy failure has gone a $230 million ...

AC Immune sees 'spots' prospective in Alzheimer's drug data

.After much more than two decades of work on neurodegenerative conditions, Swiss biotech air conditi...

GSK loses ph. 2 HPV injection over shortage of best-in-class prospective

.GSK has broken up a phase 2 individual papillomavirus (HPV) vaccination coming from its pipeline af...

OS Therapies refiles $6M IPO to fund HER2 medicine, preclinical ADCs

.Operating system Therapies will note on the NYSE American inventory swap today via a $6.4 million I...

ALX's fizzling CD47 response cost delivers supply spiraling down

.ALX Oncology's stage 2 stomach cancer reaction price has actually weakened. After viewing its CD47 ...

Ionis centers eye condition from targets of Roche-partnered prospect after information dissatisfy

.Yet Another of Ionis Pharmaceuticals' key midphase readouts has fallen short of desires, prompting ...

Biogen's chief executive officer pointed out no high-risk handle 2023. He prepares to be bold

.While Biogen's pharma peers are seeking for late-stage properties with little danger, chief executi...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Bio has actually been a biotech seeking a pipe after it scrapped its own lead properties ove...